home | contact us

To be removed from the Early Stage East Mailing List, click here, and then click send in the e-mail window. Please note any forwards on your e-mail address in the body of the e-mail.

3 Mill Road, Suite 201A
Wilmington, DE 19806
Ph: 302.777.2460
Fax: 302.777.1620

The Capital Markets Panel

Bio-Life-Tech 2004 featured a panel of experts on capital markets, discussing all the maturities of investing for growth companies - from early stage through IPOs.

Panel moderated by:
Steve Hurly, Managing Director, Janney Montgomery Scott

Panel members:
Steve Cohen,Partner, Morgan Lewis
Bruce Poignant, Vice President of Marketing, American Stock Exchange
Brian Rye, Director - Equity Research, Janney Montgomery Scott
Gerald Schaafsma, General Partner, Anthem Capital, L.P.
Doug Swirsky, Principal, Head of Life Sciences, Legg Mason Wood Walker, Inc.

Gerald Schaafsma gave the VC view on early stage investing.

Steve Cohen discussed IPO preparation.

Bruce Poignant talked about listing on an exchange.

Brian Rye spoke about the Biotech IPO market from the buy-side point of view.

Doug Swirsky spoke about the state of the capital markets.

These presentations were followed by a question and answer session with the audience.

refund privacy disclaimer exhibitor guidelines